Skip to main content
LIFEHealthcare

Atyr Pharma Inc (LIFE) Insider Trading

In the last 90 days, 18 Atyr Pharma Inc (LIFE) insiders reported no open-market purchases and 26 sales totaling $99,738,852. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 16, 2026Peter George ColisCEO and SecretarySale120,000$38.39$4,607,376
Oct 15, 2026Lingke WangPresidentSale118,333$38.36$4,538,733
Sep 18, 2026Peter George ColisCEO and SecretarySale70,000$38.51$2,695,427
Sep 17, 2026Lingke WangPresidentSale118,333$38.96$4,610,443
Aug 21, 2026Peter George ColisCEO and SecretarySale84,448$33.11$2,795,710
Aug 20, 2026Lingke WangPresidentSale118,333$33.29$3,939,732
Aug 20, 2026Brandt Walter KucharskiChief Accounting OfficerSale8,735$32.47$283,665
Aug 20, 2026Sc Us (ttgp) Ltd.Corporate insiderSale142,616$33.05$4,713,231
Aug 20, 2026Sequoia Capital U.S. Venture Fund Xv L.P.Corporate insiderSale142,616$33.05$4,713,231
Aug 20, 2026Sequoia Capital U.S. Venture Xv Principals Fund L.P.Corporate insiderSale142,616$33.05$4,713,231

Common questions

LIFE insider trading FAQ

Are LIFE insiders buying or selling?
Over the last 90 days, LIFE insiders were net sellers, reporting $0.00 of open-market purchases and $99,738,852 of sales.
When was the last LIFE insider purchase?
No open-market insider purchase of Atyr Pharma Inc stock was reported in the last 90 days.
Where does LIFE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Atyr Pharma Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.